Bank of Montreal
IMDX

Bank of Montreal’s Insight Molecular Diagnostics IMDX Stock Holding History

Bank of Montreal’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-112
Closed -$12K – 4546
2021
Q1 		$12K Sell
112
-380
-77% -$36.1K ﹤0.01% 4283
2020
Q4 		$31K Buy
492
+346
+237% +$12.7K ﹤0.01% 4208
2020
Q3 		$4K Sell
146
-28
-16% -$803 ﹤0.01% 4517
2020
Q2 		$4K Buy
+174
New +$8.98K ﹤0.01% 4456
2020
Q1 		– Sell
-137
Closed -$6K – 4515
2019
Q4 		$6K Buy
137
+42
+44% +$1.51K ﹤0.01% 4668
2019
Q3 		$4K Buy
95
+5
+6% +$197 ﹤0.01% 4581
2019
Q2 		$4K Buy
+90
New +$7.48K ﹤0.01% 4699
2018
Q4 		– Sell
-67
Closed -$3K – 4794
2018
Q3 		$3K Hold
67
– – ﹤0.01% 4249
2018
Q2 		$3K Hold
67
– – ﹤0.01% 4264
2018
Q1 		$3K Buy
67
+64
+2,133% +$4.23K ﹤0.01% 3999
2017
Q4 		$0 Buy
3
+1
+50% +$113 ﹤0.01% 4282
2017
Q3 		$0 Hold
2
– – ﹤0.01% 4278
2017
Q2 		$0 Buy
+2
New +$228 ﹤0.01% 4245
2016
Q3 		– Sell
-5
Closed – – 4145
2016
Q2 		$0 Hold
5
– – ﹤0.01% 4255
2016
Q1 		$0 Buy
+5
New +$443 ﹤0.01% 4342

Other funds holding IMDX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's IMDX Position: Q2 2021 in Review

Bank of Montreal sold out of Insight Molecular Diagnostics (IMDX) in Q2 2021, closing a stake of 112 shares — an estimated $12K sold.

Bank of Montreal first reported a position in IMDX in Q1 2016 and held it in 15 quarters. The position peaked at $31K in Q4 2020. 90 funds tracked by Wall St. Rank hold IMDX as of Q2 2021.

  • Bank of Montreal reported no remaining Insight Molecular Diagnostics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 112 Insight Molecular Diagnostics shares in Q2 2021, an estimated $12K.
  • Bank of Montreal first reported a position in Insight Molecular Diagnostics in Q1 2016 and held it in 15 quarters.
  • Bank of Montreal's Insight Molecular Diagnostics position peaked at $31K in Q4 2020.
  • 90 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.